Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Testing effectiveness (Phase 2)Study completedNCT04983030
What this trial is testing

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Who this might be right for
HIVAcquired Immunodeficiency SyndromeImmunologic Deficiency Syndrome, Acquired+2 more
Boris Juelg, MD PhD 28
Testing effectiveness (Phase 2)Study completedNCT04426695
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 2,252
Not applicableWithdrawnNCT04573634
What this trial is testing

A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition

Who this might be right for
Covid19SARS-CoV Infection
Jill M Kolesar
Testing effectiveness (Phase 2)Study completedNCT04634409
What this trial is testing

Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

Who this might be right for
COVID-19
Eli Lilly and Company 1,755
Testing effectiveness (Phase 2)Active Not RecruitingNCT06508749
What this trial is testing

The Tatelo Plus Study

Who this might be right for
HIVHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 41
Testing effectiveness (Phase 2)Study completedNCT00478465
What this trial is testing

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Who this might be right for
Chronic Fatigue Syndrome
Stanford University 30
Early research (Phase 1)Study completedNCT00114699
What this trial is testing

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

Who this might be right for
HIV Infections
Human Genome Sciences Inc. 40
Not applicableUnknownNCT02044588
What this trial is testing

Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients

Who this might be right for
HBsAg(+) Donor Kidney AllograftHBsAg(-) Donor Kidney Allograft
Chulalongkorn University 100
Not applicableStudy completedNCT03430388
What this trial is testing

Yellow Fever Vaccine in Patients With Rheumatic Diseases

Who this might be right for
Systemic LupusRheumatoid ArthritisSpondyloarthritis+8 more
University of Sao Paulo General Hospital 600
Not applicableStudy completedNCT05268601
What this trial is testing

COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

Who this might be right for
COVID-19
University of Milano Bicocca 251
Early research (Phase 1)Study completedNCT03883620
What this trial is testing

Safety Study of Dengushield in Healthy Adults

Who this might be right for
Phase 1Dengue
Serum Institute of India Pvt. Ltd. 40
Not applicableUnknownNCT04954937
What this trial is testing

Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.

Who this might be right for
Healthy
NHS Blood and Transplant 100
Not applicableUnknownNCT04842305
What this trial is testing

Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination

Who this might be right for
Covid19
Lenanrt Friis-Hansen 500
Early research (Phase 1)Study completedNCT03428347
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Who this might be right for
Healthy
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)Study completedNCT03526848
What this trial is testing

3BNC117 and 10-1074 in ART-treated Individuals

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 26
Early research (Phase 1)Study completedNCT06585891
What this trial is testing

Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)WithdrawnNCT01443117
What this trial is testing

Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women

Who this might be right for
Pneumococcal InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT04479631
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

Who this might be right for
COVID-19
Brii Biosciences Limited 16
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Next Page